“Stark RJ. Polymyositis presenting with severe weakness involving only one arm. Australian & New Zealand Journal of Medicine 1978; 8:544-546.
Wodak J, Stark RJ, Gilligan BS. Bromocriptine in lieu of levodopa for Parkinson’s disease. Medical Journal of Australia 1978; 2 (supplement Nov 4):28-31
Stark RJ. Spasticity due to phenytoin toxicity. Medical Journal of Australia 1979; 1:156.
Gilligan BS, Wodak J, Stark RJ, O’Halloran M. Comparison of enteric-coated levodopa with levodopa-carbidopa combination: a double blind cross over trial. Medical Journal of Australia 1979; 2:205-207.
Stark RJ. Supranuclear ophthalmoplegia with basilar artery aneurysms. Surgical Neurology 1979; 12:447-452.
Stark RJ. Eosinophilic polymyositis. Archives of Neurology 1979; 36:721-722
Rail D, Stark RJ, Swash M, Newland A. Improvement in nerve conduction after plasma exchange for Guillain-Barre syndrome. Journal of Neurology Neurosurgery & Psychiatry 1980; 43:1147.
Stark RJ, Kennard C, Swash M. Hand wasting in spondylotic high cord compression; an electromyographic study. Annals of Neurology 1981; 9:58-62.
Stark RJ. Reversible myoclonus with uraemia. British Medical Journal 1981; 282:1119-1120.
Stark RJ, Henson RA. Cerebral compression by myeloma. Journal of Neurology Neurosurgery & Psychiatry 1981; 44:833-836.
Stark RJ, Henson RA, Evans SJW. Spinal metastases; a retrospective survey from a general hospital. Brain 1982; 105:184-205.
Morgan-Hughes JA, Hayes DJ, Clark JB, Landon DN, Swash M, Stark RJ, Rudge P. Mitochondrial encephalopathies: biochemical studies in two cases revealing defects in the respiratory chain. Brain 1982;
105:553-582.
Stark RJ, Wodak J. Primary orthostatic cerebral ischaemia. Journal of Neurology Neurosurgery & Psychiatry 1983; 46:883-891.
Stark RJ. Neurological predictors of outcome from stroke. Proceedings of the Australian College of Rehabilitation Medicine 1984; 246-258.
Stark RJ. Haemodynamic TIAs: do they exist? In: Donnan GA, Vajda FJE, eds. Problem areas in acute stroke management. Melbourne: Department of Neurology Austin Hospital, 1984; 29-33.
Frayne J, Stark RJ. Peripheral neuropathy with gammopathy responding to plasmapheresis. Clinical & Experimental Neurology 1985;21:195-200.
Griffiths JD, Stark RJ, Ding JC, Cooper IA. Vincristine neuropathy in Charcot-Marie-Tooth syndrome. Medical Journal of Australia 1985; 143:305-306.
Griffiths JD, Ding JC, Stark RJ, Cooper IA. Vincristine neurotoxicity enhanced in combination chemotherapy including both teniposide and vincristine. Cancer Treatment Reports 1986; 70:519-521.
Waterston JA, Stark RJ, Gilligan BS. Paramedian thalamic and midbrain infarction: the “mesencephalothalamic syndrome“. Clinical & Experimental Neurology 1988; 24:45-53.
Butler EG, Dohrmann PJ, Stark RJ. Spinal subdural abscess. Clinical & Experimental Neurology 1989; 25:67-70.
Butler EG, Stark RJ, Siu K, Sinclair R. Cerebral deposits of carcinoid tumour. Clinical & Experimental Neurology 1989; 26:213-217.
Horne MK, Butler EG, Gilligan BS, Wodak J, Stark RJ, Brazenor GA Intraventricular infusion of dopamine in Parkinson’s disease. Annals of Neurology 1989; 26:792-794.
Halmagyi GM, Brandt TH, Dieterich M. Curthoys IS, Stark RJ, Hoyt WF. Tonic contraversive ocular tilt reaction due to unilateral meso-diencephalic lesion. Neurology 1990; 40:1503-1509.
Thyagarajan D, Stark RJ, Frayne J, Gilligan BS, Sacharias N. Thrombolytic therapy in vertebrobasilar occlusion. Clinical & Experimental Neurology 1992; 29:129-142.
Thyagarajan D, Bastian I, Stark RJ, Day BJ, Dax EM, Gilligan BS. HTLV-I associated myelopathy in a Seychellois immigrant. Medical Journal of Australia 1993; 159:29-31.
Kinsella G, Olver J, Ng K, Packer S, Stark RJ. Analysis of the syndrome of unilateral neglect. Cortex 1993; 29:135-140.
Kinsella G, Packer S, Ng K, Olver J, Stark RJ. Continuing issues in the assessment of neglect. Neuropsychological Rehabilitation 1995; 5:239-258.
Nestor PJ, Stark RJ. Vitamin B myeloneuropathy precipitated by nitrous oxide anaesthesia. Medical Journal of Australia 1996; 165:174.
Faragher MW, Stark RJ, Street A. Hunter syndrome complicated by hydrocephalus and an endogenous anticoagulant. Journal of Clinical Neuroscience 1997; 4:252-255.
Hand PJ, Stark RJ. Intravenous lignocaine infusions for severe chronic daily headache. Medical Journal of Australia 2000; 172:157-159.
Stark RJ, Dahlof C, Haughie S, Hettiarachchi J on behalf of the Eletriptan Steering Committee. Efficacy, safety and tolerability of oral eletriptan in the acute treatment of migraine: results of a phase III multicentre, placebo-controlled study across three attacks. Cephalalgia 2002; 22:23-32.
Mileshkin L, Michael M, O’Reilly M, McKenzie A, Stark R. CNS Listeriosis confused with leptomeningeal carcinomatosis in a patient with malignant insulinoma. American Journal of Clinical Oncology 2002; 25:576-579.
Williams DR, Stark RJ. Intravenous lignocaine (lidocaine) infusion for the treatment of chronic daily headache with substantial medication overuse. Cephalalgia 2003; 23:963-971.
Tam CS, Galanos J, Seymour JF, Pitman AG, Stark RJ, Prince HM. Reversible posterior leukoencephalopathy syndrome complicating cytotoxic chemotherapy for hematologic malignancies. American Journal of Hematology 2004; 77:72-76.
Mileshkin L. Stark R. Day B. Seymour JF. Zeldis JB. Prince HM. Development of neuropathy in patients with myeloma treated with thalidomide: patterns of occurrence and the role of electrophysiologic monitoring. Journal of Clinical Oncology. 2006; 24:4507-14.
Stark RJ, Valenti L, Miller GC. Management of migraine in Australian general practice. Medical Journal of Australia 2007; 187:142-146.
Stark RJ, Stark CD. New drugs, old drugs: Migraine prophylaxis. Medical Journal of Australia 2008; 189:283-288.
Stark RJ. Commentary: Development and validation of the Asian Migraine Criteria (AMC). J Clin Neurosci 2012; 19:229-230
Stark RJ, Ravishankar K, Siow HC, Lee KS, Pepperle R, Wang SJ. Chronic migraine and chronic daily headache in the Asia–Pacific region: a systematic review. Cephalalgia 2013; 33:266-283. (Published Online First Cephalalgia 2012; e-published ahead of print Dec 2012.)
Stark R. Clinical testing of visual fields using a laser pointer and a wall. Practical Neurology 2013;13:4 258-259 (Published Online First: 26 April 2013 doi:10.1136/practneurol-2013-00056)
Foster E, Tsang BKT, Kam A, Stark RJ. Mechanisms of upper limb amyotrophy in spinal disorders. J Clin Neurosci 2014;21:1209–1214. (Published Online First: http://dx.doi.org/10.1016/j.jocn.2013.10.035)
Papandony M, Wesselingh R, Stark R. Uhthoff phenomenon in osmotic demyelination syndrome. Internal Medicine Journal 2014; 44:1144-1145.
Stark CD, Stark RJ. Sleep and chronic daily headache. Current Pain and Headache Reports 2015; 19(1):468.
Löscher WN, Tschugg A, Wanschitz JV, Stark RJ, Grams AE. Hand amyotrophy and ventral intraspinal fluid collection. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 2015; 16(5-6):412-3.
Greythorn62
Stark RJ, McGuire T, van Driel M. Medication overuse headache in Australia: a call for multidisciplinary efforts at prevention and treatment Medical Journal of Australia 2016; 205 (6): 283.
Thorlund K, Toor K Wu P, Chan K, Druyts E, Ramos E, Bhambri R, Donnet A, Stark R, Goadsby PJ. Comparative tolerability of treatments for acute migraine: A network meta-analysis Cephalalgia 2017;37 (10): 965-978. (Published Online First: 2016: 10.1177/0333102416660552).
Cheng S, Stark CD, Stark RJ. Sleep apnoea and the neurologist. Pract Neurol 2017;17:21–27. (Published Online First: doi:10.1136/practneurol-2016-0015242016)
Ziff M, Stark RJ. How to assess tendon reflexes of the lower limb in the elderly. Journal of Neurological Sciences 2017;372: 196–200 (First published on-line 2016; http://dx.doi.org/10.1016/j.jns.2016.11.044)
van Driel M, McGuire T, Stark RJ, Lazure P, Garcia T, Sullivan L. Learnings and challenges to deploy an interprofessional and independent medical education programme to a new audience, Journal of European CME 2017; 6:1, 1400857, DOI: 10.1080/21614083.2017.1400857
Blumenfeld AM, Stark RJ, Freeman MC, Orejudos A, Manack Adams A. Long-Term Study of the Efficacy and Safety of OnabotulinumtoxinA for the Prevention of Chronic Migraine: COMPEL Study. The Journal of Headache and Pain 2018; 19:13 DOI 10.1186/s10194-018-0840-8
Van Driel ML, Anderson E, McGuire TM, Stark R. Medication overuse headache: strategies for prevention and treatment using a multidisciplinary approach. Hong Kong Med J 2018; 24:617-22.
Aung AK, Robinson J, Hey P, Lehmann M, Chow Y, Stark RJ, Bosco JJ. Progressive Multifocal Leukoencephalopathy Secondary to Hepatitis C Virus Infection Related T-cell Lymphopaenia. Internal Medicine Journal 2019 49:114-118.
Stark C, Stark R, Limberg N, Rodrigues J, Cordato D, Schwartz, R, Jukic R. Real-World Effectiveness of OnabotulinumtoxinA Treatment for the Prevention of Headaches in Adults With Chronic Migraine in Australia: A Retrospective Study. The Journal of Headache and Pain 2019 (First published on-line) https://doi.org/10.1186/s10194-019-1030-z
Ellis, S, Rang C, Kotsimbos T, Keating D, Finlayson F, Stark R, Thyagarajan D, Wilson J. CNS imaging studies in cystic fibrosis patients presenting with sudden neurological events. BMJ Open Respiratory Research 2019;6:e000456. doi:10.1136/ bmjresp-2019-000456
Tan TH, Stark RJ, Waterston JA, Thyagarajan D, White OB, Monif M. Genetic Prion Disease: D178N with MV129 disease modifying polymorphism – an exploration of clinical phenotype. BMJ Neurology Open 2020; 2:e000074. http://dx.doi.org/10.1136/bmjno-2020-000074
Stark RJ. Tips for Trainees: Some Practical Tips on Clinical examination. Practical Neurology 2020; 20:489-493 http://pn.bmj.com/cgi/content/full/practneurol-2020-002659v1?ct
Ray JC, Kapoor M, Stark RJ, Wang SJ, Bendtsen L, Matharu M, Hutton EJ. Calcitonin Gene Related Peptide in migraine: current therapeutics, future implications and potential off-target effects. Journal of Neurology Neurosurgery & Psychiatry 2021 https://jnnp.bmj.com/content/early/2021/01/25/jnnp-2020-324674)
Ray JC, Allen P, Bacsi A, Bosco JJ, Chen L, Eller M, Kua H, Lim LL, Matharu M, Monif M, Ruttledge M, Stark RJ, Hutton EJ. Inflammatory complications of CGRP monoclonal antibodies: a case series. The Journal of Headache and Pain 2021; 22:121 https://doi.org/10.1186/s10194-021-01330-7
Koshy K, Schneckenburger, Stark R, Fitzgerald M. Delayed onset sequential bilateral abducens nerve palsies secondary to traumatic CSF leak. Trauma Case Reports 2022; https://doi.org/10.1016/j.tcr.2021.100602
Ray JC, Stark RJ, Hutton EJ. Cluster headache in adults. Australian Prescriber 2022;45:15-20.
https://doi.org/10.18773/ austprescr.2022.004
Ray JC, Cheng S, Tsan K, Hussain H, Stark RJ, Matharu M, Hutton EJ. Intravenous lidocaine and ketamine infusions for headache disorders: a retrospective cohort study. Frontiers in Neurology 2022;13:842082. https://doi.org/10.3389/fneur.2022.842082.
Wijeratne T, Bassetti CA, Grisold W, Dodick D, Rouleau G, Lewis SL, Stark R, Freedman M, Guekht A, Gouider R, Medina MT, Meshram C, Basri H, Charway-Felli A, Naseer MA. Brain health for all on World Brain Day 2022. Lancet Neurology 2022; https://doi.org/10.1016/S1474-4422(22)00295-2
Grisold W, Karlshoej K, Freedman M, Gouider R, Guekht A, Lewis SL, Medina MT, Meshram C, Rouleau G, Stark RJ. Brain health as a global priority, view from WHO: Editorial from the World Federation of Neurology, Journal of the Neurological Sciences, 2022; https://doi.org/10.1016/j.jns.2022.120337
Grisold W, Freedman M, Gouider R, Guekht A, Lewis S, Medina M, Meshram C, Rouleau G, Stark R, on behalf of the Trustees of the World Federation of Neurology. The Intersectoral Global Action Plan (IGAP): A unique opportunity for neurology across the globe. Journal of the Neurological Sciences, 2023; https://doi.org/10.1016/j.jns.2023.120645
Tamborska AA, Wood GK, Westenberg E, Garcia-Azorin D, Webb G, Schiess N, Netravathi M, Baykan B, Dervaj R, Helbok R, Lant S, Özge A, Padovani A, Saylor D, Schmutzhard E, Easton A, Lilleker JB, Jackson T, Beghi E, Ellul MA, Frontera JA, Pollak T, Nicholson TR, Wood N, Thakur KT, Solomon T, Stark RJ, Winkler AS, Michael BD, Global NeuroResearch Coalition. Global uncertainty in the diagnosis of neurological complications of SARS-CoV-2 infection by both neurologists and non[1]neurologists: An international inter-observer variability study. Journal of the Neurological Sciences, 2023; https://doi.org/10.1016/j.jns.2023.120646
Wijeratne T, Jenkins B, Stark RJ, Sun-Edelstein C. Assessing and managing medication overuse headache in Australian clinical practice. BMJ Neurology Open 2023;5:e000418. doi:10.1136/ bmjno-2023-000418
Fish D, Jennens I, Taggart G, Seward L, Stark R. Clinical guidelines to the rating of impairments arising from infectious occupational diseases. Victoria Government Gazette G30, 27 July 2006, 1587-1594.
Speck G, Brownbill D, Dickens R, Hall S, Stark R, Wilde P. Spinal Impairment Guides Modification Document. Victoria Government Gazette S305, 6 October 2016, 1-19.
BOOK CHAPTERS
Stark RJ. Stroke. In: Hughes ESR, Buzzard AJ, Hughes GRT, Wells JDB, eds. Medicine & Surgery for Lawyers. Sydney: The Law Book Company, 1986; 56-64.
Stark RJ. Headache. In: Hughes ESR, Johnson WR, Milne PY, Polglase AL (eds); Cabrini Surgical Lectures, ESR Hughes, Malvern, 1989.
Stark RJ. Stroke. In: Buzzard AJ, Hughes ESR, Hughes GRT, Wells JDB, eds. Medicine & Surgery for Lawyers (2nd edition). Sydney: The Law Book Company, 1996.
Stark RJ. Chapter 18: Central Nervous System Risk Assessment and Chapter 56: Epilepsy. In Symons J, Myles P, Mehra R, Ball C. Perioperative Medicine for the Junior Clinician. Wiley-Blackwell, Oxford, UK, 2015
Stark RJ, Hutton E, Cheng S. Painful Cranial Neuropathies: Facial Pain and Cervicogenic Headache. In Ravishankar K, Evans RW and Wang SJ. Modern Day Management of Headache. Jaypee Brothers Medical Publishers, New Delhi, India 2017
Paemeleire K, Vandenbussche N, Stark RJ. Handbook of Clinical Neurology. Chapter 11: Migraine without aura. In Swanson JW, Matharu M (eds) Handbook of Clinical Neurology, Elsevier, Volume 198, 2023, Pages 151-167, ISSN 0072-9752, ISBN 9780128233566, https://doi.org/10.1016/B978-0-12-823356-6.00007-X.
Stark, RJ. (2023). Examination Tips in Suspected First Presentation with Multiple Sclerosis. In: Junckerstorff, R., Brady, S., Aung, A.K. (eds) Beyond Evidence-Based Medicine. Springer, Singapore. https://doi.org/10.1007/978-981-99-4440-8_96
Stark, RJ. (2023). Migraine Aura: Typical and Atypical. In: Junckerstorff, R., Brady, S., Aung, A.K. (eds) Beyond Evidence-Based Medicine. Springer, Singapore. https://doi.org/10.1007/978-981-99-4440-8_97
Stark, RJ. (2023). Acute Transient Amnesia. In: Junckerstorff, R., Brady, S., Aung, A.K. (eds) Beyond Evidence-Based Medicine. Springer, Singapore. https://doi.org/10.1007/978-981-99-4440-8_98
Stark, RJ. (2023). Wasted First Dorsal Interosseous Muscle: What Does It Mean?. In: Junckerstorff, R., Brady, S., Aung, A.K. (eds) Beyond Evidence-Based Medicine. Springer, Singapore. https://doi.org/10.1007/978-981-99-4440-8_99
Stark, RJ. (2023). Waking with a Weak Hand: Cortical Stroke Versus Radial Palsy. In: Junckerstorff, R., Brady, S., Aung, A.K. (eds) Beyond Evidence-Based Medicine. Springer, Singapore. https://doi.org/10.1007/978-981-99-4440-8_100
Stark RJ. Cancer and the brain: neurological complaints may be the first sign of malignancy. General Practitioner 1979;(Nov 9):30-31.
Stark RJ, CHECK programme on neurology. Royal Australian College of General Practitioners CHECK programme 1982; unit 128 (Sep).
Stark RJ. Dementia. Notes on Neurology, Australian Brain Foundation 1982; 3:1-4.
Stark RJ. Neurological disorders due to metastases. Australian Family Physician 1983; 12:110-113.
Stark RJ. Neurological predictors of outcome from stroke. Proceedings of the Australian College of Rehabilitation Medicine 1984; 246-258.
Stark RJ. Haemodynamic TIAs: do they exist? In: Donnan GA, Vajda FJE, eds. Problem areas in acute stroke management. Melbourne: Department of Neurology Austin Hospital, 1984; 29-33.
Stark RJ. CHECK programme on neurology. Royal Australian College of General Practitioners CHECK programme 1988; unit 196 (May).
Stark RJ. How to treat severe headache. Australian Doctor 2005 (19 August): 29-36.
Stark RJ. Headache prevention in a patient with hypertension. Medicine Today 2006; 7:75-76.
Stark RJ, Roberts H, Day B. CHECK program: Neurology. Royal Australian College of General Practitioners CHECK program 2007; unit 422 (May).
Stark RJ. Topiramate for migraine prevention. Medicine Today 2008; 9:79-80. (Republished as:
Stark RJ. Topiramate for migraine prevention. Modern Medicine of South Africa 2009; October:65-66.)
Stark CD, Stark RJ. Management of migraine. Medicine Today 2010; 11(4):16-24.(Republished as:
Stark CD, Stark RJ. Management of migraine. Medicine Today – Pain Management-2 2010; 24-29, and
Stark CD, Stark RJ. Management of migraine. Modern Medicine of South Africa 2011; April:8-12.), and
Stark CD, Stark RJ. Management of migraine. Modern Medicine Middle East 2011; 28:20-26.
Stark RJ. Investigation of headache. Medicine Today 2010; 11(12):50-57. .(Republished as:
Stark RJ. Investigation of headache. Modern Medicine of South Africa 2012; Jan:28-33), and
Stark RJ. Investigation of headache. Medical Progress 2012; May 245-251).
Stark RJ, Hutton E. Chronic migraine and other types of chronic daily headache Medicine Today 2013; 14(1): 29-35, and
Stark RJ, Hutton E. Chronic migraine and other types of chronic daily headache Modern Medicine of South Africa 2014; June: 15-21
Hutton E, Stark RJ. Episodic migraine in women. Medicine Today 2013; 14(2): 42-48
Hutton E, Stark RJ. Unusual primary headaches. Medicine Today 2013; 14(10): 38-44
Stark RJ. How to treat migraine. Australian Doctor 2014 (19 December): 17-24
Cheng S, Stark RJ. Novel approaches to managing migraine and cluster headaches Medicine Today 2016; 17(6): 69-71
Cheng S, Stark RJ. Thunderclap headache. Medicine Today 2017; 18(7): 14-19
McCoy D, Lintzeris N, Stark R. A man with chronic recurrent headaches self-medicating with codeine. Pain Management Today 2018; 5(1): 32-40.
Ray JC, Hutton EJ, Cheng S, Zhang L, Stark RJ. New horizons in migraine therapy: CGRP monoclonal antibodies. Medicine Today 2021; 22(6): 61-64.
Tsang B, Costello C, Jenkins B, Stark R. Diagnosing migraine with confidence. Medical Republic 2022; https://medicalrepublic.com.au/diagnosing-migraine-with-confidence/61169?utm_source=website&utm_medium=listings-search&utm_campaign=tsang
Hilliard T, Ray JC, Hutton EJ, Stark RJ. Migraine in 2022: an update on management. Medicine Today 2022; 23(9): 57-64.
Stark RJ. Does migraine exist? Commentary. World Neurology. www.wfneurology.org. Oct-Dec 2022. P3
Stark RJ. Tournament of Minds. World Neurology. www.wfneurology.org. Jan-Feb 2023. P13
Stark RJ. Headache: Investigating the cause. Medicine Today 2023; 24(6): 29-36.
Cheng T, Ray JC, Hilliard T, Stark RJ. Rimegepant – a new oral migraine medication. Medicine Today 2024; 25(1-2): 35-37
Gunasekera L, Ray JC, Stark R Medication overuse headache Less is MOH. Pain Management Today 2024; 11(1): 66-69
Winkler AS, Leonardi M, Michael BD, Abd-Allah F, Carroll W, Guekht A, and the Global COVID-19 Neuro Research Coalition A WHO resolution on epilepsy and other neurological disorders. The Lancet Neurology, Volume 20, Issue 3, 171 – 172
Beghi E, Michael BD, Solomon T, Winkler AS, on behalf of the COVID-19 Neuro Research Coalition. Approaches to understanding COVID-19 and its neurological associations: present and future. Annals of Neurology https://doi.org/10.1002/ana.26076
Donnan GA, Davis SM, Chambers BR, Gates PC, Hankey GJ, McNeil JJ, Rosen D, Stewart-Wynne EG, Tuck RR, for the Australian Streptokinase (ASK) Trial Study Group. Streptokinase for acute ischaemic stroke with relationship to time of administration. JAMA, 1996;276:961-966. (Member of Safety Committee)
Davis SM, Donnan GA, Parsons MW, et al. Eff ects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol 2008; 7: 299–309. (Member of Safety Committee)
WHO: Atlas of headache disorders and resources in the world 2011. http://www.who.int/mental_health/management/atlas_headache_disorders/en/index.html (Respondent)
Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders,
3rd edition (beta version) Cephalalgia 2013:33;629–808 (contributor)
Campbell BCV, Mitchell PJ, Kleinig TJ, Dewey HM, Churilov L, Yassi N, Yan B, Dowling RJ, Parsons MW, Oxley TJ, Wu TY, Brooks M, Simpson MA, Miteff F, Levi CR, Krause M, Harrington TJ, Faulder KC, Steinfort BS, Priglinger M, Ang T, Scroop R, Barber PA, McGuinness B, Wijeratne T, Phan TG, Chong W, Chandra RV, Bladin CF, Badve M, Rice H, de Villiers L, Ma H, Desmond PM, Donnan GA, Davis SM, on behalf of the EXTEND-IA investigators. Endovascular Therapy for Ischemic Stroke with Perfusion Imaging Selection. N Engl J Med 2015, 372:1009-1018 (ePub 11/02/15). (Member of Safety Committee)
Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders,
3rd edition Cephalalgia 2018:38;1-211 (contributor)
Campbell BCV, van Zwam WH, Goyal M, Menon BK, Dippel DWJ, Demchuk AM, Bracard S White P, Dávalos A, Majoie CBLM, van der Lugt A, Ford GA, Pérez de la Ossa N, Kelly M, Bourcier R, Donnan GA, Roos YBWEM, Bang OY, Nogueira RG, Devlin TG, van den Berg LA, Clarençon F, Burns P, Carpenter J, Berkhemer OA, Yavagal DR, Pereira VM, Ducrocq X, Dixit A, Quesada H, Epstein J, Davis SM, Jansen O, Rubiera M, Urra X, Micard E, Lingsma HF, Naggara O, Brown S, Guillemin F, Muir KW, van Oostenbrugge RJ, Saver JL, Jovin TG, Hill MD, Mitchell PJ for the HERMES collaborators. Effect of general anaesthesia on functional outcome among patients with anterior circulation ischaemic stroke undergoing endovascular thrombectomy versus standard care: a meta-analysis of individual patient data from seven randomised controlled trials. Lancet Neurology 2018, 17:47-53 (ePub 16/12/17) (Member of Safety Committee)
Campbell BCV, Mitchell PJ, Churilov L, Keshtkaran M, Hong KS, Kleinig TJ, Dewey HM, Yassi N, Yan B, Dowling RJ, Parsons MW, Wu TY, Brooks M, Simpson MA, Miteff F, Levi CR, Krause M, Harrington TJ, Faulder KC, Steinfort BS, Ang TA, Scroop R, Barber PA, McGuinness B, Wijeratne T, Phan TG, Chong W, Chandra RV, Bladin CF, Rice H, de Villiers L, Ma H, Desmond PM, Meretoja A, Cadilhac DA, Donnan GA, Davis SM on behalf of the EXTEND-IA investigators. Endovascular Thrombectomy for Ischemic Stroke Increases Disability-Free Survival, Quality of Life and Life Expectancy and Reduces Cost. Frontiers in Neurology 2017, ePub 14/12/17. (Member of Safety Committee)
Campbell BCV, Mitchell PJ, Churilov L, Yassi N, Kleinig TJ, Dowling RJ, Yan B, Bush SJ, Dewey HM, Thijs V, Scroop R, Simpson M, Brooks M, Asadi H, Wu TY, Shah DG, Wijeratne T, Ang T, Miteff F, Levi CR, Rodrigues E, Zhao H, Salvaris P, Garcia-Esperon C, Bailey P, Rice H, de Villiers L, Brown H, Redmond K, Leggett D, Fink JN, Collecutt W, Wong AA, Muller C, Coulthard A, Mitchell K, Clouston J, Mahady K, Field D, Ma H, Phan TG, Chong W, Chandra RV, Slater LA, Krause M, Harrington TJ, Faulder KC, Steinfort BS, Bladin CF, Sharma G, Desmond PM, Parsons MW, Donnan GA, Davis SM, on behalf of the EXTEND-IA TNK investigators. Tenecteplase Versus Alteplase Before Thrombectomy for Ischemic Stroke. N Engl J Med 2018, 378:1573-82. (Member of Safety Committee)
Young W, Lopez J, Rothrock J, Orejudos A, Manack Adams A, Lipton R, Blumenfeld A. Effects of OnabotulinumtoxinA Treatment in Patients With and Without Daily Headache at Baseline: Results From the COMPEL Study. The Journal of Headache and Pain 2019; 20:10 10.1186/s10194-018-0952-1 (Investigator)
Ma H, Campbell BCV, Parsons MW, Churilov L, Levi CR, Hsu C, Kleinig TJ, Wijeratne T, Curtze S, Dewey HM, Miteff F, Tsai C-H, Lee J-T, Phan TG, Mahant N, Sun M-C, Krause M, Sturm J, Grimley R, Chen C-H, Hu C-J, Wong AA, Field D, Sun Y, Barber PA, Sabet A, Jannes J, Jeng J-S, Clissold B, Markus R, Lin C-H, Lien L-M, Bladin CF, Christensen S, Yassi N, Sharma G, Bivard A, Desmond PM, Yan B, Mitchell PJ, Thijs V, Carey L, Meretoja A, Davis SM, Donnan GA, for the EXTEND Investigatorset al. Thrombolysis guided by perfusion imaging up to 9 hours after onset of stroke. N Engl J Med 2019;380:1795-803. DOI: 10.1056/NEJMoa1813046 (Member of Safety Committee)
Campbell BCV, Ma H, Ringleb PA, Parsons MW, Churilov L, Bendszus M, Levi CR, Hsu C, Kleinig TJ, Fatar M, Leys D, Molina C, Wijeratne T, Curtze S, Dewey HM, Barber PA, Butcher KS, De Silva DA, Bladin CF, Yassi N, Pfaff JAR, Sharma G, Bivard A, Desmond PM, Schwab S, Schellinger PD, Yan B, Mitchell PJ, Serena J, Toni D, Thijs V, Hacke W, Davis SM, Donnan GA, on behalf of the EXTEND, ECASS-4, and EPITHET Investigators‡ Extending thrombolysis to 4·5–9 h and wake-up stroke using perfusion imaging: a systematic review and meta-analysis of individual patient data The Lancet 2019:394(10193) DOI: 10.1016/S0140-6736(19)31053-0 (Member of Safety Committee)
Thomalla G, Boutitie F, Ma H, Koga M, Ringleb P, Schwamm LH, Wu O, Bendszus M, Bladin CF, Campbell BCV, Cheng B, Churilov L, Ebinger M, Endres M, Fiebach JB, Fukuda-Doi M, Inoue M, Kleinig TJ, Latour LL, Lemmens R, Levi CR, Leys D, Miwa K, Molina CA, Muir KW, Nighoghossian N, Parsons MW, Pedraza S, Schellinger PD, Schwab S, Simonsen CZ, Song SS, Thijs V, Toni D, Hsu CY, Wahlgren N, Yamamoto H, Yassi N, Yoshimura S, Warach S, Hacke W, Toyoda K, Donnan GA, Davis SM, Gerloff C; Evaluation of unknown Onset Stroke thrombolysis trials (EOS) investigators. Intravenous alteplase for stroke with unknown time of onset guided by advanced imaging: systematic review and meta-analysis of individual patient data. Lancet. 2020 Nov 14;396(10262):1574-1584. doi: 10.1016/S0140-6736(20)32163-2. Epub 2020 Nov 8.PMID: 33176180 (Member of Safety Committee)
Liebeskind DS, Bracard S, Guillemin F, Jahan R, Jovin TG, Majoie CB, Mitchell PJ, van der Lugt A, Menon BK, San Román L, Campbell BC, Muir KW, Hill MD, Dippel DW, Saver JL, Demchuk AM, Dávalos A, White P, Brown S, Goyal M; HERMES Collaborators. eTICI reperfusion: defining success in endovascular stroke therapy. J Neurointerv Surg. 2019 May;11(5):433-438. doi: 10.1136/neurintsurg-2018-014127. Epub 2018 Sep 7.PMID: 30194109 (Member of Safety Committee)
Campbell BCV, Majoie CBLM, Albers GW, Menon BK, Yassi N, Sharma G, van Zwam WH, van Oostenbrugge RJ, Demchuk AM, Guillemin F, White P, Dávalos A, van der Lugt A, Butcher KS, Cherifi A, Marquering HA, Cloud G, Macho Fernández JM, Madigan J, Oppenheim C, Donnan GA, Roos YBWEM, Shankar J, Lingsma H, Bonafé A, Raoult H, Hernández-Pérez M, Bharatha A, Jahan R, Jansen O, Richard S, Levy EI, Berkhemer OA, Soudant M, Aja L, Davis SM, Krings T, Tisserand M, San Román L, Tomasello A, Beumer D, Brown S, Liebeskind DS, Bracard S, Muir KW, Dippel DWJ, Goyal M, Saver JL, Jovin TG, Hill MD, Mitchell PJ; HERMES collaborators. Penumbral imaging and functional outcome in patients with anterior circulation ischaemic stroke treated with endovascular thrombectomy versus medical therapy: a meta-analysis of individual patient-level data. Lancet Neurol. 2019 Jan;18(1):46-55. doi: 10.1016/S1474-4422(18)30314-4. Epub 2018 Nov 6.PMID: 30413385 (Member of Safety Committee)
Campbell BCV, van Zwam WH, Goyal M, Menon BK, Dippel DWJ, Demchuk AM, Bracard S, White P, Dávalos A, Majoie CBLM, van der Lugt A, Ford GA, de la Ossa NP, Kelly M, Bourcier R, Donnan GA, Roos YBWEM, Bang OY, Nogueira RG, Devlin TG, van den Berg LA, Clarençon F, Burns P, Carpenter J, Berkhemer OA, Yavagal DR, Pereira VM, Ducrocq X, Dixit A, Quesada H, Epstein J, Davis SM, Jansen O, Rubiera M, Urra X, Micard E, Lingsma HF, Naggara O, Brown S, Guillemin F, Muir KW, van Oostenbrugge RJ, Saver JL, Jovin TG, Hill MD, Mitchell PJ; HERMES collaborators. Effect of general anaesthesia on functional outcome in patients with anterior circulation ischaemic stroke having endovascular thrombectomy versus standard care: a meta-analysis of individual patient data. Lancet Neurol. 2018 Jan;17(1):47-53. doi: 10.1016/S1474-4422(17)30407-6. Epub 2017 Dec 16. Erratum in: Lancet Neurol. 2019 Mar;18(3):e2. PMID: 29263006. (Member of Safety Committee)
Román LS, Menon BK, Blasco J, Hernández-Pérez M, Dávalos A, Majoie CBLM, Campbell BCV, Guillemin F, Lingsma H, Anxionnat R, Epstein J, Saver JL, Marquering H, Wong JH, Lopes D, Reimann G, Desal H, Dippel DWJ, Coutts S, du Mesnil de Rochemont R, Yavagal D, Ferre JC, Roos YBWEM, Liebeskind DS, Lenthall R, Molina C, Al Ajlan FS, Reddy V, Dowlatshahi D, Sourour NA, Oppenheim C, Mitha AP, Davis SM, Weimar C, van Oostenbrugge RJ, Cobo E, Kleinig TJ, Donnan GA, van der Lugt A, Demchuk AM, Berkhemer OA, Boers AMM, Ford GA, Muir KW, Brown BS, Jovin T, van Zwam WH, Mitchell PJ, Hill MD, White P, Bracard S, Goyal M; HERMES collaborators. Imaging features and safety and efficacy of endovascular stroke treatment: a meta-analysis of individual patient-level data. Lancet Neurol. 2018 Oct;17(10):895-904. doi: 10.1016/S1474-4422(18)30242-4. Epub 2018 Sep 18.PMID: 30264728 (Member of Safety Committee)
Campbell BCV, Mitchell PJ, Churilov L, Yassi N, Kleinig TJ, Dowling RJ, Yan B, Bush SJ, Thijs V, Scroop R, Simpson M, Brooks M, Asadi H, Wu TY, Shah DG, Wijeratne T, Zhao H, Alemseged F, Ng F, Bailey P, Rice H, de Villiers L, Dewey HM, Choi PMC, Brown H, Redmond K, Leggett D, Fink JN, Collecutt W, Kraemer T, Krause M, Cordato D, Field D, Ma H, O’Brien B, Clissold B, Miteff F, Clissold A, Cloud GC, Bolitho LE, Bonavia L, Bhattacharya A, Wright A, Mamun A, O’Rourke F, Worthington J, Wong AA, Levi CR, Bladin CF, Sharma G, Desmond PM, Parsons MW, Donnan GA, Davis SM; EXTEND-IA TNK Part 2 investigators. Effect of Intravenous Tenecteplase Dose on Cerebral Reperfusion Before Thrombectomy in Patients With Large Vessel Occlusion Ischemic Stroke: The EXTEND-IA TNK Part 2 Randomized Clinical Trial. JAMA. 2020 Apr 7;323(13):1257-1265. doi: 10.1001/jama.2020.1511.PMID: 32078683 (Member of Safety Committee)
Gotz T and 777 other authors including Stark RJ. Intravenous alteplase for stroke with unknown time of onset guided by advanced imaging: systematic review and meta-analysis of individual patient data. 2020 The Lancet 2020; 396(10262):1574-1584.
Yogendrakumar, V., Beharry, J., Churilov, L., Alidin, K., Ugalde, M., Pesavento, L., Weir, L., Mitchell, P. J., Kleinig, T. J., Yassi, N., Thijs, V., Wu, T. Y., Shah, D. G., Dewey, H. M., Wijeratne, T., Yan, B., Desmond, P. M., Sharma, G., Parsons, M. W., & Donnan, G. A. (2022). Tenecteplase Improves Reperfusion Across Time in Large Vessel Stroke. Annals of Neurology., ja. https://doi.org/10.1002/ana.26547”
© 2025 Cure Systems
